Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis

Zehtab, Shahrzad; Bardsiri, Mahla Sattarzadeh; Khalilabadi, Roohollah Mirzaee; Ehsan, Mohsen; Fatemi, Ahmad

doi:10.1186/s13104-022-05918-3

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Preprint1

Article1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Synergistic Effect of Proteasome Inhibitor Bortezomib and Parp1 Inhibitor Niraparib in Multiple Myeloma Through Induction of DNA Damage and Inhibition of DNA Repair

Haiyan,

Cheng,

Zhao

et al. 2024

Preprint

View full text Add to dashboard Cite

Synergistic Effect of Proteasome Inhibitor Bortezomib and Parp1 Inhibitor Niraparib in Multiple Myeloma Through Induction of DNA Damage and Inhibition of DNA Repair

Haiyan,

Cheng,

Zhao

et al. 2024

Preprint

View full text Add to dashboard Cite

Diagnostic and Prognostic Value of DNA Repair Gene XRCC1 ARG399GLN Polymorphism in Childhood Acute Lymphoblastic Leukemia: A Single-Center Egyptian Study

Hablas,

Mahmoud,

Qassem

et al. 2024

Alexandria Journal of Pediatrics

View full text Add to dashboard Cite

Background Repair pathways for DNA damage are essential for repairing various forms of DNA damage. Leukemia risk may be increased by poor DNA repair. This study was conducted to better understand the significance of XRCC1Arg399 Gln polymorphisms in acute lymphoblastic leukemia (ALL) susceptibility and prognosis. Patients and methods Twenty children with ALL participated in the pediatric trial at Tanta University. Thirty healthy controls were of the same age and sex. Complete blood counts, bone marrow aspirates, immunophenotyping, flow cytometry, and XRCC1 genotyping by PCR were performed. Results The allele Gln/Gln was found in one (3.3%) of the controls and two (10%) cases had an odds ratio of 0.13 (0.27–38.1), P=0.34. Eight (40%) patients and six controls [odds ratio of 2.66 (0.75–9.4), P=0.11], had the Arg/Gln allele. Finally, 23 (76.7%) members of the control group and 10 (50%) patients carried this allele (Arg/Arg). The genotype’s prognostic value for alleles: two (20%) of patients with the allele (Arg/Arg) were refractory. Two (25%) patients died during the induction for the allele (Arg/Gln), while four (50%) patients were refractory. Last but not least, no one experienced total remission under the allele (Gln/Gln). Conclusion The XRCC1 polymorphism is not linked to the development of ALL; nevertheless, having mutant alleles was linked to a poorer prognosis.

show abstract

Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis

Cited by 2 publications

References 46 publications

Synergistic Effect of Proteasome Inhibitor Bortezomib and Parp1 Inhibitor Niraparib in Multiple Myeloma Through Induction of DNA Damage and Inhibition of DNA Repair

Synergistic Effect of Proteasome Inhibitor Bortezomib and Parp1 Inhibitor Niraparib in Multiple Myeloma Through Induction of DNA Damage and Inhibition of DNA Repair

Diagnostic and Prognostic Value of DNA Repair Gene XRCC1 ARG399GLN Polymorphism in Childhood Acute Lymphoblastic Leukemia: A Single-Center Egyptian Study

Contact Info

Product

Resources

About